Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07387640

Synchronized Core-Pelvic Floor Activation in Urinary Incontinence

This study aims to investigate whether co-activation of the pelvic floor and core muscles improves treatment outcomes in individuals with urinary incontinence. Participants diagnosed with stress, or mixed urinary incontinence will undergo a 12-week pelvic floor physiotherapy program, with or without additional core muscle co-activation exercises. Changes in urinary incontinence severity, pelvic floor muscle function, core muscle activation, and quality of life will be evaluated.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Urinary incontinence is a prevalent condition that negatively affects quality of life and functional independence. Pelvic floor muscle training (PFMT) is recommended as a first-line conservative treatment. Recent evidence suggests that coordinated activation of the pelvic floor muscles with core muscles, including the transversus abdominis and multifidus, may enhance treatment effectiveness.

This randomized controlled study will include women aged 18-65 years diagnosed with stress or mixed urinary incontinence. Eligible participants will be randomly allocated to one of two groups: a conventional pelvic floor muscle training group (control group) or a pelvic floor muscle training plus core muscle co-activation group (intervention group).

Both groups will participate in a 12-week exercise program performed at least three days per week, including one supervised session and two home-based sessions weekly. Outcome measures will be assessed at baseline and after completion of the intervention. Primary outcomes include urinary incontinence severity, while secondary outcomes include pelvic floor muscle function, core muscle activation assessed by surface electromyography, and quality of life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 18 and 65 years
  • Diagnosed with stress, urge, or mixed urinary incontinence
  • Pelvic floor muscle strength grade ≥ 3 according to the Modified Oxford Scale
  • At least one episode of urinary leakage within the last month

Exclusion criteria

  • Pregnancy
  • Childbirth within the previous 6 weeks
  • Severe pelvic organ prolapse
  • Active vaginal or urinary tract infection
  • Presence of neurological or psychiatric disorders
  • Malignancy
  • Inability to cooperate with assessments or interventions

Treatment and study plan

Conventional Pelvic Floor Muscle Training

Other

Participants will receive conventional pelvic floor muscle training based on standardized pelvic floor physiotherapy principles. Exercises will be performed for 12 weeks, at least three days per week, including one supervised session and two home-based sessions.

Pelvic Floor and Core Muscle Co-activation Training

Other

Participants will receive pelvic floor muscle training combined with co-activation exercises targeting core muscles. The program will be conducted for 12 weeks with the same frequency and supervision structure as the control group.

Primary outcomes

  1. International Consultation on Incontinence Questionnaire

    Time frame: 12 weeks

    This is a brief patient-reported questionnaire used to assess the frequency, severity, and impact of urinary incontinence on quality of life.

    Minimum Score: 0

    Maximum Score: 21

    Interpretation: Higher scores indicate worse symptoms and a greater impact on quality of life.

    Breakdown: The score is the sum of three items: frequency (0-5), amount (0-6), and interference with everyday life (0-10).

Secondary outcomes

  1. PERFECT scheme

    Time frame: 12 weeks

    This is used to evaluate Pelvic Floor Muscle Function. It evaluates four components: Power, Endurance, Repetitions, and Fast contractions. Higher scores indicate better muscle function

  2. Surface electromyography

    Time frame: 12 weeks

    This is used to evaluate Core and Pelvic Floor Muscle Activation

  3. Urogenital Distress Inventory (UDI-6)

    Time frame: 12 weeks

    This questionnaire assesses the degree of bother associated with specific urogenital symptoms (e.g., frequent urination, leakage).

    Minimum Score: 0

    Maximum Score: 100 (Standardized Scale)

    Interpretation: Higher scores indicate worse quality of life (higher distress).

    Calculation: There are 6 items. Each is rated 0 (Not at all) to 3 (Greatly). The average score of the items is calculated and then multiplied by 33.33 to convert it to a 0-100 scale.

  4. the Incontinence Impact Questionnaire (IIQ-7)

    Time frame: 12 weeks

    This questionnaire measures the impact of urinary incontinence on activities, roles, and emotional health.

    Minimum Score: 0

    Maximum Score: 100 (Standardized Scale)

    Interpretation: Higher scores indicate worse quality of life (greater negative impact).

    Calculation: There are 7 items. Each is rated 0 (Not at all) to 3 (Greatly). Like the UDI-6, the average of the item scores is multiplied by 33.33 to obtain the final 0-100 score.

Study contacts

Contact information is provided by the study sponsor or research team.

Betul Çınar

CONTACT

[email protected]

+902125232288 ext. 4648

Betül Çınar

CONTACT

[email protected]

+902125232288 ext. 4648

Sponsors and collaborators

Lead sponsor

Bezmialem Vakif University

Other

Registry information

Official study title

Synchronized Activation of Core and Pelvic Floor Muscles: A More Effective Strategy for Urinary Incontinence?

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 4, 2026
Registry last updated
Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.